Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section


November-December 2003 edition

  • Anergy Testing for Tuberculosis
  • Phosphate Binding Agents Used in the Treatment of Hyperphosphatemia
  • Medication Safety - NEW Dangerous Drug Abbreviations
  • P&T Committee Formulary Action - November 2003

September-October 2003 edition

  • Caring for pain at UIMCC
  • FDA hormone replacement therapy Web site
  • P&T Committee Formulary Action - September 2003

July-August 2003 edition

  • Review of Clostridium Difficile - Diagnosis and Management
  • Anaphylactoid Reactions to Radiocontrast Media
  • Medication Safety: Subcutaneous Administration of Heparin and Low Molecular Weight Heparin
  • P&T Committee Formulary Action - July 2003

May-June 2003 edition

  • Smallpox Update
  • Sliding Insulin
  • Medication Safety: Adult Critical Care Drip Sheet Heparin Dosing Rule
  • P&T Committee Formulary Action - March and May 2003

January-February 2003 edition

  • Atrial fibrillation: rate versus rhythm control AFFIRM and RACE trials
  • B-type natriuretic peptide – a useful diagnostic marker for heart failure?
  • P&T Committee Formulary Action
  • Enoxaparin Administration Information